KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 55 filers reported holding KALA PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | – | 1,597 | +27.9% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 1,249 | -68.9% | 0.00% | – |
| Q1 2022 | $5,000 | -64.3% | 4,021 | -63.8% | 0.00% | – |
| Q4 2021 | $14,000 | -17.6% | 11,101 | +73.8% | 0.00% | – |
| Q3 2021 | $17,000 | -32.0% | 6,386 | +42.0% | 0.00% | – |
| Q2 2021 | $25,000 | -3.8% | 4,497 | +13.1% | 0.00% | – |
| Q1 2021 | $26,000 | +62.5% | 3,975 | +73.5% | 0.00% | – |
| Q4 2020 | $16,000 | +433.3% | 2,291 | +420.7% | 0.00% | – |
| Q3 2020 | $3,000 | -76.9% | 440 | -63.6% | 0.00% | – |
| Q2 2020 | $13,000 | +550.0% | 1,208 | +325.4% | 0.00% | – |
| Q1 2020 | $2,000 | -60.0% | 284 | -76.6% | 0.00% | – |
| Q4 2019 | $5,000 | +400.0% | 1,213 | +500.5% | 0.00% | – |
| Q3 2019 | $1,000 | -87.5% | 202 | -83.8% | 0.00% | – |
| Q2 2019 | $8,000 | +700.0% | 1,250 | +681.2% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 160 | +6.7% | 0.00% | – |
| Q4 2018 | $1,000 | -66.7% | 150 | -57.5% | 0.00% | – |
| Q3 2018 | $3,000 | +50.0% | 353 | +135.3% | 0.00% | – |
| Q2 2018 | $2,000 | -90.0% | 150 | -88.0% | 0.00% | – |
| Q1 2018 | $20,000 | +900.0% | 1,254 | +1117.5% | 0.00% | – |
| Q4 2017 | $2,000 | -88.2% | 103 | -85.9% | 0.00% | – |
| Q3 2017 | $17,000 | – | 731 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,142,360 | $7,745,000 | 4.83% |
| RA Capital Management | 10,874,613 | $73,730,000 | 1.03% |
| Mesirow Financial Investment Management, Inc. | 43,431 | $294,462,000 | 0.93% |
| Parkman Healthcare Partners LLC | 272,445 | $1,847,000 | 0.47% |
| Samsara BioCapital, LLC | 601,162 | $4,076,000 | 0.41% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $693,000 | 0.40% |
| Eventide Asset Management | 3,450,000 | $23,391,000 | 0.36% |
| Orbimed Advisors | 5,465,030 | $37,053,000 | 0.32% |
| Vivo Capital, LLC | 786,883 | $5,335,000 | 0.24% |
| Knights of Columbus Asset Advisors LLC | 169,429 | $1,149,000 | 0.12% |